Cambridge centre among top two in Europe for cancer research
The Cancer Research UK Cambridge Centre has become the first UK institute to be designated a Comprehensive Cancer Center of Excellence by the European Academy of Cancer Sciences (EACS).
It means Cambridge is one of the top two cancer centres in Europe for outstanding academic research, alongside the Netherlands Cancer Institute.
The Cancer Research UK Cambridge Centre is now the largest CRUK Cancer Centre by funding, totalling approximately £100million a year. More than 600 laboratory and healthcare professionals are based there.
Professor Carlos Caldas, director of the Breast Cancer Programme and lead for European collaborations at the CRUK Cambridge Centre, said: “This new and prestigious designation by the EACS is for us an enormous privilege and also a responsibility. This designation only makes us even more focused in delivering outstanding clinical care for our patients underpinned by the world-class research programmes at the University and CRUK Cambridge Institute.”
Dr Anton Berns, who chairs the EACS committee overseeing the Designation of Excellence process, said: “This is the type of setting that will make a difference for cancer patients and that is precisely why they are so deserving of this prestigious title.
“Clearly, an example for other institutions to follow.”